Tuesday, March 28, 2017

Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year by KATIE THOMAS


By KATIE THOMAS

The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.

Published: March 27, 2017 at 08:00PM

from NYT Health http://ift.tt/2nIKI6n
via IFTTT




from WordPress http://ift.tt/2nJnD3f
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)